Burnout Syndrome Among Diabetes Specialist Trainee Registrars in United Kingdom

January 10, 2024 updated by: Dr Adnan Agha, United Arab Emirates University

Assessing the Frequency of Burnout Syndrome Among Diabetes Specialist Trainee Registrars in United Kingdom and Identifying Any Associated Factors

Burnout Syndrome is a medical condition caused by long-term job-related strain and is defined by presence of either one or more of the three states i.e. emotional exhaustion, depersonalization and lack of personal accomplishment. Burnout has been shown to cause decreased work output and mental well being of employees and increase errors at workplace. Burnout is observed in various lines of work and but has been found to be especially high among healthcare professionals. Diabetes Mellitus is a generally a life-long condition and diabetes specialists deal with patients of this chronic condition frequently. The burnout among diabetes specialist trainees in United Kingdom was found to be over 50% in a study done in pre-pandemic times in 2018 and there is a need to repeat this study to see if there any change in terms of presence of burnout in this group of health care professionals.

Study Overview

Detailed Description

Burnout syndrome can develop after a prolonged response to chronic emotional and interpersonal workplace stressors, and is defined by 3 dimensions - emotional exhaustion, depersonalization and lack of personal accomplishment. The consequences of burnout on an employee can be on a psychological and somatic level as well as on her/his ability to perform work, and hospital physicians with burnout have higher sickness and absenteeism and decreases work output. Burnout among physicians can also lead to medical mistakes and increasing the odds for workplace failure with adverse affects in their attitude towards their work. Research has shown that doctors reporting high workload and a unsupported work climate have higher stress, burnout and dissatisfaction with their career.

Study done by author previously in 2018 among Diabetes specialist registrars in England Scotland and Wales identified burnout syndrome in 57.5% respondents with commonest self-reported stressors being workload and lack of specialty training. In order to address this problem nationally, there is need to re-assess the presence of burnout and then consider planning for any interventional steps that may help reduce burnout.

Study Type

Observational

Enrollment (Actual)

104

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Abu Dhabi
      • Al Ain, Abu Dhabi, United Arab Emirates, 15551
        • Internal Medicine, College of Medicine and Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 60 years (Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

All the doctors fulfilling the above criteria will be sent an online invite to participate in this survey via national organizations on their emails as well as via official online platform. The online forms will remain open over 3 months period. The participants meeting the above-mentioned criteria will be selected and they will complete the self-reported profroma containing demographics and Maslach burnout inventory ( a validated tool via Mind Garden TM for Burnout Syndrome) on an online secure platform. No personal identifiable information will be collected or stored and the results will be displayed in the form of deanery / national cumulative results.

Description

Inclusion Criteria:

  1. All specialty doctors working in Diabetes or Endocrinology department post foundation years, in the following deaneries/regions in United Kingdom

    • Health Education Yorkshire & Humber
    • Health Education East Midlands
    • Health Education East of England
    • Health Education Kent Surrey & Sussex
    • Health Education North West & Mersey Deanery
    • Health Education North East
    • Health Education South West Peninsula and Severn Deanery
    • Health Education Thames Valley (Oxford)
    • Health Education Wessex
    • Health Education West Midlands
    • London Deanery (North West, North Central & East London, South London)
    • Northern Ireland Medical & Dental Training Agency
    • Scotland Deanery (West, South East, East, North)
    • Wales Deanery
  2. Doctors currently working for the last 3 months in either one of the following posts:

    • Clinical fellow/ non-deanery training post/locally employed trainee
    • Academic clinical fellow trainee / ACF
    • Core Trainee or Specialist trainee year 3/ awaiting National Training Number
    • Associate Specialist Equivalent/Trust middle grade
    • Specialist trainee year 4 through year 8
    • Clinical Lecturer
    • Diabetes consultant (new i.e within 3 years of appointment, locum, fixed term or substantive)
  3. Currently working in UK for at least six months in the last one year
  4. Agreeing to participate via informed consent

Exclusion Criteria:

  • Self-reported presence of mental health illness and/or active treatment.
  • Not currently working for more than 3 months e.g on sick leave.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Diabetes Specialist trainee Registrars/Middle grade working in UK
All doctors in in middle grade or similar rank who are in training as Diabetes Specialist trainee Registrars or non-trainee Middle grade doctors working in Diabetes/Endocrinology department in NHS Wales, NHS Scotland or Health and Social Care northern Ireland (health systems in all of UK)
Using Maslach Burnout inventory to assess the presence of burnout and a self reporting questionnaire to identify possible stressors or associations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identify any self-reported stressors associated with burnout
Time Frame: 6 months
To assess the presence of associated self-reported factors for burnout syndrome
6 months
Identify burnout
Time Frame: 6 months
To assess the frequency of burnout syndrome in Diabetes and Endocrinology specialty trainee registrars in all of United Kingdom by using a validated tool via Mind Garden, Malasch Inventory for Burnout Syndrome, latest edition 2016, assessing all three subscales of burnout i.e Emotional Exhaustion (with cutoff score for high burnout as per standardized z value = Mean + (SD* 0.5); range 0-54 with higher scores meaning a worse outcome), Depersonalization (with cutoff score for high burnout as per standardized z value = Mean + (SD * 1.25); range 0-30 with higher scores meaning a worse outcome), and lack of personal accomplishment (with cutoff score for high burnout per standardized z value = Mean + (SD * 0.10); range 0-48 with higher scores meaning a better outcome)
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare any change in presence of burnout from previous cross-sectional study (5 years ago)
Time Frame: 12 months
To compare the frequency of burnout syndrome in Diabetes and Endocrinology specialty trainee registrars in all of UK done in 2022-2023 with frequency of burnout syndrome in Diabetes and Endocrinology specialty trainee registrars in 2018 (previous survey published and data available for comparison.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adnan Agha, United Arab Emirates University, College of Medicine & Health Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 5, 2022

Primary Completion (Actual)

January 31, 2023

Study Completion (Actual)

September 30, 2023

Study Registration Dates

First Submitted

July 27, 2022

First Submitted That Met QC Criteria

July 27, 2022

First Posted (Actual)

July 29, 2022

Study Record Updates

Last Update Posted (Estimated)

January 11, 2024

Last Update Submitted That Met QC Criteria

January 10, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The individual data will be non identifiable and without personal identifiable information. can consider collaboration with other researchers at later stage

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe